{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:12:30Z","timestamp":1790010750339,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019713","name":"VA Pittsburgh Healthcare System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI174041"],"award-info":[{"award-number":["R21AI174041"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijregi.2026.100946","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:34:41Z","timestamp":1783726481000},"page":"100946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019"],"prefix":"10.1016","volume":"20","author":[{"given":"Adeel A.","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obaid S.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzna I.","family":"Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4236-1618","authenticated-orcid":false,"given":"Ahmed","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amyn A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100946_bib0001","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ijregi.2026.100946_bib0002","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijregi.2026.100946_bib0003","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jsps.2023.04.002","article-title":"Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines","volume":"31","author":"Matyori","year":"2023","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.ijregi.2026.100946_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/ph15020151","article-title":"Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer","volume":"15","author":"Morofuji","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijregi.2026.100946_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.27835","article-title":"Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: results from ERCHIVES","volume":"62","author":"Butt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ijregi.2026.100946_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: results from ERCHIVES","volume":"64","author":"Simon","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ijregi.2026.100946_bib0007","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2005.05.056","article-title":"Effects of statins beyond lipid lowering: potential for clinical benefits","volume":"109","author":"Almuti","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijregi.2026.100946_bib0008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1465-9921-6-82","article-title":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia","volume":"6","author":"Mortensen","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.ijregi.2026.100946_bib0009","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.rmed.2010.04.005","article-title":"Statins in community acquired pneumonia: evidence from experimental and clinical studies","volume":"104","author":"Chalmers","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.ijregi.2026.100946_bib0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.5114\/aoms\/149633","article-title":"The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis","volume":"18","author":"Vahedian-Azimi","year":"2022","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ijregi.2026.100946_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16357-2","article-title":"Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study","volume":"12","author":"Santosa","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijregi.2026.100946_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.877944","article-title":"The impact of HMG-CoA Reductase Inhibitors use on the clinical outcomes in critically ill patients with COVID-19: a multicenter, cohort study","volume":"10","author":"Al Sulaiman","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijregi.2026.100946_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076195","article-title":"Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19","volume":"13","author":"Rong","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijregi.2026.100946_bib0014","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMoa2309995","article-title":"Simvastatin in critically ill patients with Covid-19","volume":"389","author":"Hills","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2026.100946_bib0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5414\/CP204446","article-title":"A meta-analysis of randomized controlled trials of statin-based therapy in patients with COVID-19","volume":"61","author":"Kao","year":"2023","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ijregi.2026.100946_bib0016","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15537\/smj.2024.45.2.20230589","article-title":"Statin use and clinical outcomes in hospitalized COVID-19 patients: a retrospective analysis in Riyadh, Saudi Arabia","volume":"45","author":"Alshaalan","year":"2024","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ijregi.2026.100946_bib0017","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.abe6522","article-title":"Immunological characteristics govern the transition of COVID-19 to endemicity","volume":"371","author":"Lavine","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijregi.2026.100946_bib0018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S2213-2600(23)00217-5","article-title":"WHO ends the COVID-19 public health emergency","volume":"11","author":"Burki","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijregi.2026.100946_bib0019","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ijregi.2026.100946_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295052","article-title":"Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality","volume":"18","author":"Funaki","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100946_bib0021","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1093\/cid\/ciab1023","article-title":"Rate and risk factors for severe\/critical disease among fully vaccinated persons with breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a high-risk national population","volume":"75","author":"Butt","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100946_bib0022","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/s41467-022-31402-4","article-title":"COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods","volume":"13","author":"Mayr","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijregi.2026.100946_bib0023","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ijregi.2026.100946_bib0024","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5306\/wjco.v11.i8.573","article-title":"Statins in risk-reduction and treatment of cancer","volume":"11","author":"Barbalata","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ijregi.2026.100946_bib0025","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/cancers15153948","article-title":"Statins in cancer prevention and therapy","volume":"15","author":"Ricco","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijregi.2026.100946_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.20222","article-title":"Association of statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality","volume":"6","author":"Vell","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijregi.2026.100946_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2026.100946_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.ijregi.2026.100946_bib0029","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.3748\/wjg.v21.i27.8293","article-title":"Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes","volume":"21","author":"Simon","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ijregi.2026.100946_bib0030","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijregi.2026.100946_bib0031","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/healthcare11142049","article-title":"The health status of the US veterans: a longitudinal analysis of surveillance data prior to and during the COVID-19 pandemic","volume":"11","author":"Betancourt","year":"2023","journal-title":"Healthcare (Basel)"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:42:54Z","timestamp":1790008974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2772707626001086"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100946","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100946"}}